KIM JONES: Open Payments
NPI 1245874981 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,301 in 59 payments from 10 companies in 2025. Trend: 2023 $52 · 2024 $366 · 2025 $1,301
Food & beverage: $1,295Education: $5
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 17 | $245 |
| Axsome Therapeutics, Inc. | 7 | $227 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $186 |
| E.R. Squibb & Sons, L.L.C. | 8 | $184 |
| Lundbeck LLC | 5 | $105 |
| ABBVIE INC. | 6 | $99 |
| Teva Pharmaceuticals USA, Inc. | 2 | $94 |
| Alkermes, Inc. | 3 | $59 |
| Vanda Pharmaceuticals Inc. | 3 | $56 |
| Merck Sharp & Dohme LLC | 2 | $44 |
Products named: INVEGA SUSTENNA, Auvelity, CAPLYTA, COBENFY, ABILIFY ASIMTUFII, VRAYLAR, UZEDY, ARISTADA.
Industry payments across MS — which companies pay providers there.
